Lista de obras -

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease

scientific article published on 30 August 2018

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study

artículo científico publicado en 2017

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

scientific article published on 13 June 2019

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease

artículo científico publicado en 2018

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

artículo científico publicado en 2020

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

artículo científico publicado en 2017

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

artículo científico publicado en 2018

Methotrexate for psoriasiform lesions associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease ⬇️

artículo científico publicado el 2 de abril de 2012

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

artículo científico publicado en 2017

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

artículo científico publicado en 2019

Review article: the natural history of postoperative Crohn's disease recurrence ⬇️

artículo científico publicado el 7 de febrero de 2012

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 02 August 2018

Role of adherent and invasive <i>Escherichia coli</i> in Crohn’s disease: lessons from the postoperative recurrence model

artículo científico publicado en 2022

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

artículo científico publicado en 2015

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

artículo científico publicado en 2019

Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's disease

artículo científico publicado en 2020

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients

scientific article published on 20 February 2020

Lista de obras de

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study

Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease

Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Methotrexate for psoriasiform lesions associated with anti‐tumour necrosis factor therapy in inflammatory bowel disease ⬇️

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial

Review article: the natural history of postoperative Crohn's disease recurrence ⬇️

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

Role of adherent and invasive <i>Escherichia coli</i> in Crohn’s disease: lessons from the postoperative recurrence model

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's disease

Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients